S&P 500 7,636.36 −0.48%
Nasdaq 26,253.34 −0.64%
S&P/TSX 35,906.56 −0.60%
Apple 315.34 −0.28%
Nvidia 223.67 −0.91%
Microsoft 491.65 −0.47%
Shopify 175.13 −5.35%
Royal Bank 285.59 −0.91%
CAD/USD 0.7243 −0.21%
CLOSED · 01:35 ET
Market ClerkRecap
Thu Sep 10 · markets closed4 signals on Sep 9217 insider buys this week · $297.2MCIRO short report next: Sep 14The week ahead
CH
INSIDER · BLTE · BELITE BIO, INC · CHIEF FINANCIAL OFFICER

Chuang Hao-Yuan

Every open-market transaction filed under this name, Sep 4 to Sep 8.

Filings
19
0 buys · 19 sells
Bought
open market, at cost
Sold
$12.8M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 8BLTEBELITE BIO, INCChief Financial OfficerSell2,562$198.05$507K
Sep 8BLTEBELITE BIO, INCChief Financial OfficerSell4,605$197.23$908K
Sep 8BLTEBELITE BIO, INCChief Financial OfficerSell4,475$196.47$879K
Sep 8BLTEBELITE BIO, INCChief Financial OfficerSell4,120$195.60$806K
Sep 8BLTEBELITE BIO, INCChief Financial OfficerSell2,200$194.28$427K
Sep 4BLTEBELITE BIO, INCChief Financial OfficerSell4,602$193.12$889K
Sep 4BLTEBELITE BIO, INCChief Financial OfficerSell3,398$192.40$654K
Sep 4BLTEBELITE BIO, INCChief Financial OfficerSell6,200$191.09$1.2M
Sep 4BLTEBELITE BIO, INCChief Financial OfficerSell1,800$190.63$343K
Sep 4BLTEBELITE BIO, INCChief Financial OfficerSell6,200$189.22$1.2M
Sep 4BLTEBELITE BIO, INCChief Financial OfficerSell1,900$188.59$358K
Sep 4BLTEBELITE BIO, INCChief Financial OfficerSell3,900$187.16$730K
Sep 4BLTEBELITE BIO, INCChief Financial OfficerSell4,600$186.34$857K
Sep 4BLTEBELITE BIO, INCChief Financial OfficerSell3,872$185.28$717K
Sep 4BLTEBELITE BIO, INCChief Financial OfficerSell3,569$184.57$659K
Sep 4BLTEBELITE BIO, INCChief Financial OfficerSell3,759$183.27$689K
Sep 4BLTEBELITE BIO, INCChief Financial OfficerSell2,000$182.49$365K
Sep 4BLTEBELITE BIO, INCChief Financial OfficerSell2,000$181.05$362K
Sep 4BLTEBELITE BIO, INCChief Financial OfficerSell1,633$180.16$294K

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.